首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Structural optimization of adaptaquin,a HIF prolyl hydroxylase inhibitor
Authors:Poloznikov  A A  Khristichenko  A Yu  Smirnova  N A  Hushpulian  D M  Gaisina  I N  Osipyants  A I  Tishkov  V I  Gazaryan  I G
Institution:1.Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology, and Immunology, 1 ul. Samory Mashela, 117997, Moscow, Russian Federation
;2.National Medical Research Radiological Center, Ministry of Health of the Russian Federation, 4 ul. Koroleva, 249036, Obninsk, Russian Federation
;3.Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood, Chicago, IL, 60612, USA
;4.Department of Chemistry, M. V. Lomonosov Moscow State University, Build 3, 1 Leninskie Gory, 119991, Moscow, Russian Federation
;5.Innovations and High Technologies MSU Ltd., 16 ul. Tsymlyanskaya, 109451, Moscow, Russian Federation
;6.A. N. Bach Institute of Biochemistry, Russian Academy of Sciences, Federal Research Center “Fundamentals of Biotechnology”, Build. 2, 33 Leninsky prosp., 119071, Moscow, Russian Federation
;
Abstract:Russian Chemical Bulletin - The structural optimization of adaptaquin, viz., 7-(4-chlorophenyl)(3-hydroxypyridin-2-yl)amino]methylquinolin-8-ol, a HIF (hypoxia inducible factor) prolyl hydroxylase...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号